Claire Emily Fletcher

6PUBLICATIONS
5CO-AUTHORS
Cancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Surface water quality processes and contaminated sediment assessmentMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 12, 2026
Fat's all, folks: culturing and manipulating peri-prostatic adipocytes to probe impacts on prostate cancer biology.

Nil Grunberg, Mathias Winkler, Giles Hellawell

|Sep 28, 2023
PLK1 Regulates MicroRNA Biogenesis through Drosha Phosphorylation.

Claire Emily Fletcher, Molly Ann Taylor, Charlotte Lynne Bevan

|Jan 09, 2023
Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer.

J N Zamarbide Losada, E Sulpice, S Combe

|Mar 23, 2022
A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer.

C E Fletcher, L Deng, F Orafidiya

|Feb 15, 2022
Crosstalk between Long Non Coding RNAs, microRNAs and DNA Damage Repair in Prostate Cancer: New Therapeutic Opportunities?

Folake Orafidiya, Lin Deng, Charlotte Lynne Bevan

|May 03, 2019
Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer.

Claire E Fletcher, Eric Sulpice, Stephanie Combe

Pageof 1

Frequent Collaborators

5 joint publications

Charlotte Lynne Bevan

1 joint publications

D A Leach

1 joint publications

X Gidrol

1 joint publications

Shawn E Lupold